Raymond James Financial Services Advisors, Inc. Repligen Corp Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 3,325 shares of RGEN stock, worth $370,504. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,325
Previous 3,219
3.29%
Holding current value
$370,504
Previous $405,000
21.98%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding RGEN
# of Institutions
492Shares Held
57.7MCall Options Held
75.6KPut Options Held
521K-
Black Rock Inc. New York, NY7.57MShares$843 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.57MShares$843 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$566 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$188 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.67MShares$187 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.18B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....